REGENERATIVE ARTIFICIAL SKIN MARKET ANALYSIS

Market News

Key Developments

Increasing research and development activities, as well as product innovations by market players are some of the key factors driving the market growth. For instance, in April 2019, South Korea-based T&R Biofab registered a patent for its 3D bioprinting technology to create artificial skin. The technology operates through the 3D printing of dermal and epidermal cells that uses a porous 3D structure to form skin with similar characteristics to actual tissue. Moreover, strategic collaborations and partnerships among key market players are expected to facilitate growth of the regenerative artificial skin market. For instance, in June 2019, South Korea-based companies, T&R Biofab and SCM Life Science, announced plans to collaborate in the research and development of new 3D printed tissue regenerative products. Strategic acquisitions and partnerships among key players are expected to drive the market growth. In May 2019, Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices entered an agreement to acquire Solsys Medical, LLC, and a regenerative medical company. The acquisition is expected to help Misonix to expand its portfolio with the addition of Solsys Medical’s wound care solutions.